Key result
Resting breath acetone correlates moderately with NT-proBNP and differs at peak effort in HF patients.
Observational (n=25)
Answers are grounded in this paper and cite their sources.
This paper describes the AEOLUS pilot study which combines breath analysis with cardiopulmonary exercise testing (CPET) and an echocardiographic examination for monitoring heart failure (HF) patients. Ten consecutive patients with a prior clinical diagnosis of HF with reduced left ventricular ejection fraction were prospectively enrolled together with 15 control patients with cardiovascular risk factors, including hypertension, type II diabetes or chronic ischemic heart disease. Breath samples were collected at rest and during CPET coupled with exercise stress echocardiography (CPET-ESE) protocol by means of needle trap micro-extraction and were analyzed through gas-chromatography coupled with mass spectrometry. The protocol also involved using of a selected ion flow tube mass spectrometer for a breath-by-breath isoprene and acetone analysis during exercise. At rest, HF patients showed increased breath levels of acetone and pentane, which are related to altered oxidation of fatty acids and oxidative stress, respectively. A significant positive correlation was observed between acetone and the gold standard biomarker NT-proBNP in plasma ( r = 0.646, p < 0.001), both measured at rest. During exercise, some exhaled volatiles (e.g., isoprene) mirrored ventilatory and/or hemodynamic adaptation, whereas others (e.g., sulfide compounds and 3-hydroxy-2-butanone) depended on their origin. At peak effort, acetone levels in HF patients differed significantly from those of the control group, suggesting an altered myocardial and systemic metabolic adaptation to exercise for HF patients. These preliminary data suggest that concomitant acquisition of CPET-ESE and breath analysis is feasible and might provide additional clinical information on the metabolic maladaptation of HF patients to exercise. Such information may refine the identification of patients at higher risk of disease worsening.
No takes yet. Share an insight, caveat, or question.
Biagini et al. (2023) conducted an observational in Heart failure with reduced left ventricular ejection fraction (n=25). Breath analysis combined with cardiopulmonary exercise testing and exercise stress echocardiography (CPET-ESE) vs. Control patients with cardiovascular risk factors (hypertension, type II diabetes, or chronic ischemic heart disease) was evaluated on Correlation between resting breath acetone and plasma NT-proBNP, and breath volatile organic compound levels during CPET-ESE (r = 0.646, p=<0.001). Breath analysis with CPET-ESE showed resting breath acetone positively correlated with plasma NT-proBNP (r=0.646, p<0.001) and differed at peak effort in HF patients vs controls.
Synapse has enriched 10 related papers. Consider them for comparative context: